12.10.2023 • News
SK Capital Acquires Food Ingredients Company J&K
Private equity group SK Capital Partners has agreed to acquire US company J&K Ingredients, currently owned by Core Industrial Partners.
News
12.10.2023 • News
Symrise Expands Partnership with Kobo Products
German flavor and fragrance company Symrise has increased its stake in in US company Kobo Products, a pigment and powder specialist, to 49%. The transaction, said Symrise, creates further opportunities for both companies in the fields of mineral UV filters and decorative cosmetics. Kobo customers are also expected to benefit from expanded capacities and global supply chains.
11.10.2023 • News
ExxonMobil to Buy Pioneer Natural Resources for $60 Billion
The US energy sector is on the verge of a mega merger: energy and petrochemical giant ExxonMobil has announced its intention to take over producer Pioneer Natural Resources. The merger is planned as an all-stock transaction valued at $59.5 billion, or $253 per share, based on ExxonMobil’s closing price on Oct. 5, 2023, according to a company statement. First reports about the ongoing negotiations already circulated last week.
11.10.2023 • News
Olon Opens New Proteins Manufacturing Site in Italy
Olon Biotech, a division of Italian API producer Olon, has inaugurated a new facility for the industrial-scale production of proteins from alternative sources at its site in Settimo, Italy. Olon pegged the investment in the new plant at €70 million.
11.10.2023 • News
GSK and Zhifei Co-Promote Shingles Vaccine in China
GSK has struck a deal with Chongqing Zhifei Biological Products to promote the British group's shingles vaccine, Shingrix, in China for an initial three-year period. Starting on Jan.1, 2024, Zhifei will have exclusive rights to import and distribute Shingrix in China through its service network of more than 30,000 vaccination points across the country.
10.10.2023 • News
Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy
Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for the first line of its new production unit at Gropello Cairoli, Italy, expanding its large scale manufacturing capabilities for high potent active pharmaceutical ingredients (HPAPIs) and steroids.
10.10.2023 • News
Bayer Opens New Cell Therapy Production Facility in the US
Bayer has opened a new cell therapy production plant in Berkeley, California, USA, for the production of of BlueRock Therapeutics’ bemdaneprocel (BRT-DA01), an investigational cell therapy currently in evaluation for treating Parkinson’s disease. BlueRock Therapeutics is a clinical-stage cell therapy company and a wholly owned, independently managed subsidiary of Bayer.
09.10.2023 • News
PCG to Build Asia’s Largest Advanced Chemical Recycling Plant
Malaysia’s leading integrated chemicals producer Petronas Chemicals Group Berhad (PCG), part of Petronas group, has reached the final investment decision (FID) to construct an advanced chemical recycling plant with a capacity of 33 kt/a. The plant, to be built in Pengerang, Johor, is the largest of its kind in Asia, said Petronas, and is expected to be operational in the first half of 2026.
09.10.2023 • News
Bristol-Myers Squibb to Acquire Mirati for up to $5.8 Billion
Bristol-Myers Squibb (BMS) announced that it will acquire Mirati Therapeutics for up to $5.8 billion. BMS is to pay $58.00 per share in cash, for a total equity value of $4.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent expirations later this decade.
06.10.2023 • News
Lonza Increases Capacity for Antibody-Drug Conjugates at Visp, Switzerland
Swiss contract development and manufacturing organization (CDMO) Lonza is extending a long-term collaboration with an unnamed major global biopharmaceutical partner. Under the agreement, the current dedicated bioconjugation capacity will be increased fourfold by adding two new bioconjugation suites for the commercial supply of antibody-drug conjugates (ADCs) at Lonza's site in Visp, Switzerland.
05.10.2023 • News
OMV and Wood Collaborate to License Chemical Recycling Technology
Austrian oil, gas and chemicals group OMV is collaborating with British engineering and consulting group Wood for the worldwide commercial licensing of OMV’s proprietary ReOil technology. The agreement follows a respective Memorandum of Understanding, that was signed between the two companies last year.
05.10.2023 • News
Kensing Acquires Advanced Organic Materials (AOM)
Kensing, a manufacturer of natural vitamin E, plant sterols, and high-purity surfactants, announced the acquisition of Advanced Organic Materials (AOM), a producer of non-GMO plant-based vitamin E and phytosterols derived from sunflower and rapeseed.
04.10.2023 • News
Eli Lilly to Acquire Radiopharmaceutical Company Point Biopharma for $1.4 Billion
Eli Lilly announced that it is acquiring radiopharmaceutical company Point Biopharma for $12.50 per share in cash, valuing the deal at approximately $1.4 billion. Point has pipeline of clinical and preclinical-stage radioligand therapies in development for the treatment of cancer. The transaction has been approved by the boards of directors of both Indianapolis-based US companies.
04.10.2023 • News
Sanofi Enters into Partnerships with Janssen and Teva
Sanofi has entered into an agreement with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, to develop and commercialize the vaccine candidate for extraintestinal pathogenic E. coli (9-valent) developed by Janssen, a potential first-in-class product currently in Phase 3.
04.10.2023 • News
AmbioPharm Appoints Brian Gregg as CEO
Contract development and manufacturing organization (CDMO) AmbioPharm has appointed industry veteran Brian Gregg as CEO. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down after seven years with the company.
03.10.2023 • News
Johnson Matthey to Deploy Low Carbon Hydrogen Production Technology to Kellas Midstream
Aberdeen, Scotland-based energy infrastructure company Kellas Midstream, in collaboration with service providers Worley and Johnson Matthey, has begun front-end engineering design (FEED) for its H2NorthEast hydrogen project at Teesside, UK.
02.10.2023 • News
AstraZeneca, SAS Team up on AI and Analytics in Clinical Trials
AI and analytics software company SAS is collaborating with global biopharmaceutical company AstraZeneca to increase efficiency and drive automation in the delivery of statistical analyses for clinical and post-approval submissions to regulatory authorities.
29.09.2023 • News
Ineos Acquires the Eastman Texas City Site
Petrochemicals giant Ineos has agreed to buy compatriot Eastman’s Texas City site, including the 600 kt acetic acid plant and all associated third party activities on the site, for about $500 million.
29.09.2023 • News
ECHA Receives a Large Number of Comments on PFAS Restriction Proposal
Per- and polyfluoroalkyl substances (PFAS) are a large group of industrial chemicals that are used in numerous industrial processes and consumer products due to their special technical properties. PFAS are difficult to degrade and are detectable in the environment, food chain and humans. Therefore, these substances are also known as "forever chemicals."
28.09.2023 • News
Borealis Appoints Two Vice Presidents within Polyolefins Business Unit
Borealis has appointed two vice presidents within its polyolefins business unit, effective Sep. 1, 2023.
28.09.2023 • News
BARDA Funds Gritstone Bio's Phase 2b Study for Covid-19 Vaccine Candidate
US biotechnology company Gritstone Bio has received a contract from the US Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase 2b comparative study evaluating the company’s self-amplifying mRNA (samRNA) vaccine candidate against Covid-19.
28.09.2023 • News
DuPont Opens New Adhesives Facility in China
DuPont officially opened its new adhesives production facility in Zhangjiagang (ZJG), eastern China, on Wednesday. The new facility will produce adhesives to serve customers in the transportation industry, primarily in lightweighting and fast-growing vehicle electrification applications, the company said.
27.09.2023 • News
Arkema to Expand Capacity for Organic Peroxides in China
Arkema plans a two-and-a-half-fold increase of its organic peroxide production capacities at the Changshu site in China. This investment of around €50 million, the company said, will enable it to support its Asian customers in fast-growing markets, particularly in renewable energies.
27.09.2023 • News
Wacker Expands Capacity for Specialty Silicones in China
Wacker Chemie started the construction of several new production lines to expand its specialty silicone manufacturing capacities at the Zhangjiagang site in Jiangsu Province, China. At the site, which is one of Wacker’s largest fully integrated production sites, the globally operating chemical group will produce functional silicone fluids, silicone emulsions and silicone elastomer gels. Investments of some €150 million are planned for the expansion project, Wacker said.
26.09.2023 • News
Galp Approves Two Major Investments at Sines Site
Portugal's oil company Galp has taken the final investment decision on two large scale projects to reduce the carbon footprint of the Sines refinery and of its products.
26.09.2023 • News
India’s Nirma to Buy API Producer Glenmark Life Sciences
Indian drugmaker Glenmark Pharma has agreed to sell 75% of the shares in its subsidiary Glenmark Life Sciences (GLS) to detergent manufacturer Nirma for 56.515 million Indian rupees (about €639.000).
26.09.2023 • News
Traceless Materials secures €36.6 Million to Build Plant
Bioeconomy startup Traceless Materials, which produces a natural biomaterial as an alternative to plastic, announces the completion of a €36.6 million funding round. The Series A financing round is led by UB Forest Industry Green Growth Fund.
25.09.2023 • News
Veranova Appoints William Sanders as Global VP of Chemical Development Operations
US contract development and manufacturing organization (CDMO) Veranova has appointed William Sanders as global vice president of chemical development operations, effective Sep. 18, 2023.
25.09.2023 • News
Novo Holdings, Gurnet Point Close Acquisition of Paratek Pharmaceuticals
Novo Holdings, controlling shareholder in drugmaker Novo Nordisk, and healthcare investment firm Gurnet Point closed their acquisition of US antibiotics specialist Paratek Pharmaceuticals in a transaction valued at $462 million. Novo Holdings said that this is its largest individual investment in antimicrobial resistance (AMR) therapies to date.
25.09.2023 • News
Sandoz Spin-off from Novartis to Start on October 4, 2023
Novartis today confirmed the plan to spin off 100% of its generic drugs arm Sandoz, with trading of the new company’s shares as well as ADRs (American Depositary Receipts) to start on Oct. 4, 2023.
22.09.2023 • News
Ineos Acquires Eramet Titanium & Iron for €230 Million
Ineos Enterprises has announced the acquisition of Eramet Titanium & Iron (ETI) from Eramet for €230 million ($245 million). The deal was completed on Sept. 21 and takes immediate effect, following the satisfaction of regulatory approvals.
21.09.2023 • News
Astellas to Build an Aseptic Drug Products Plant in Ireland
Japanese drugmaker Astellas Pharma plans to build an aseptic drug products facility in County Kerry, Ireland, creating an estimated 350 engineering, science, technology and other jobs. Construction is expected to begin next year and be completed in 2028. Astellas expects the investment costs to amount to €330 million.
20.09.2023 • News
Dow Starts Operations at New Freeport MDI Plant
Dow has started operations of its new MDI distillation and prepolymers facility at its US manufacturing site in Freeport, Texas.
20.09.2023 • News
ExxonMobil Completes Expansion of US Chemical Production at Baytown
US multinational energy company ExxonMobil has started up two new chemical production units at its Baytown, Texas, manufacturing facility. The $2 billion expansion is part of the company’s long-term growth plans for its US Gulf Coast refining and chemical facilities.
19.09.2023 • News
Solvay and Shengjian Expand Their Strategic Partnership
Belgian chemical major Solvay and China-headquartered Shanghai Shengjian Environment Technology, a company specializing on semiconductor process waste gas treatment, signed a strategic partnership framework agreement to strengthen their business relations and expand into new markets.
